After what it termed a satisfactory first half of the financial year, the board now expects current market expectations for group profit before foreign exchange revaluation and taxation for the year ending 31 March 2020 to be significantly exceeded.
The first half saw underlying profit rise 3% to £349.8mln from £340.2mln the year before.
2.00pm: Diurnal Group expects to clinch licensing deal in the first half of next year
The company said at its annual general meeting that recent pricing work had reinforced the significant commercial potential for Alkindi and the company's other lead candidate, Chronocort, in the US.
Diurnal's discussions with US partners around its late-stage cortisol deficiency pipeline continue to advance and it expects to conclude a licensing deal during the first half of next year.
12.50pm: Netcall scores after upbeat AGM statement
The shares were up 6.8% at 23.7p following a trading statement issued to coincide with the firm's annual general meeting.
"The group's pipeline is healthy and continues to show growth, driven predominately by cloud-based opportunities. The board is mindful of the current political and economic backdrop and notes that this may have an effect on customer decision making and it continues to monitor the timing of its larger enterprise and product sale contracts,” company chairman, Michael Jackson, told shareholders.
11.55am: NetScientific boosted by news of funding for Glycotest
NetScientific PLC (LON:NSCI) said investee company Glycotest Inc has received a second US$3mln tranche of its US$10mln Series A fundraising round with China’s Fosun Pharmaceutical.
The cash injection will allow Glycotest to advance towards commercial launch its algorithm-driven test for hepatocellular carcinoma, a form of liver cancer.
Shares in Netscientific were up 9.1% at 6.00p.
10.50am: Iconic Labs in surprising surge after launch of corporate website
The new media and technology business said its website includes details of the company's strategy, its board, and key investor information.
9.55am: Mitie hit by margin concerns
Mitie Group PLC (LON:MTO) dipped 2% to 140.2p in mid-morning after the company said full-year revenue growth will be in line with the first half.
The outsourcing company shared concerns over a “challenging industry of rising labour costs and margin pressures”, not helped by the widespread economic and political uncertainty, holding back sales in the second half.
Revenue in the first half was £1bn, up 11% year-on-year, a trend expected to continue until 2021.
9am: Investors see the light in Blue Prism
Robotic process automation firm Blue Prism PLC (LON:PRSM) rocketed 28% to 1,136p in early deals on the back of an upbeat trading statement.
The group has seen a “significant acceleration” in sales in the second half of the year, contributing to a very strong full-year performance.
The group is set to enter 2020 with a record order book.
Funds under management and administration increased by 2.1% year-on-year to £24.6bn in the six months to the end of September, with discretionary funds up by 6.1% to £13.9bn.
Underlying profit before tax increased by 71.9% to £9.8mnln from £5.7mln in the first million of the previous financial year.